HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Seeks Public Input To Craft Guidance For Nanotech Products

This article was originally published in The Rose Sheet

Executive Summary

FDA has scheduled a public meeting Sept. 8 to gather information about the possible effects of nanotechnology; input the agency receives could help shape future guidances, according to an Aug. 7 Federal Register notice

You may also be interested in...

Report Contests “Unsubstantiated” Nanotech Concerns, Touts Nano-Sunscreen

Current evidence suggests that nano-sized cosmetic ingredients pose no more risk to human health than their macro-sized counterparts, L'Oréal researchers maintain in a review published this month in Skin Pharmacology and Physiology

Pharma's Reform Bounce: How Big a Bounce Will $80 Bil. Buy?

Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.

King's CorVu Gets Reluctant "No" From Advisory Committee

Despite voting that King's CorVu is not equivalent to its study comparator, Cardio-Renal panel sees bright future for the stress agent.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts